TUCRIN will be a partner in COMBACTE (Combatting Bacterial Resistance in Europe), a project under the Innovative Medicines Initiative (IMI) funded New Drugs for Bad Bugs (ND4BB) program. TUCRIN will find and help coordinate potential participating sites for the ASPIRE-ICU trial. Potential sites in Turkey will be contacted via TUCRIN with an official letter of invitation from COMBACTE.

Click for more information about COMBACTE
Click for more information about ASPIRE-ICU trial